Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.51 USD | +7.09% | +1.20% | -18.39% |
22/04 | Adial Pharmaceuticals Granted US Patent for Genetic Diagnostic, AD04 Combination to Treat Alcohol Use Disorder | MT |
12/04 | Top Premarket Decliners | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.39% | 57.17L | |
+34.26% | 5.08TCr | |
+0.37% | 4.28TCr | |
+49.62% | 4.2TCr | |
-4.96% | 2.95TCr | |
+10.94% | 2.61TCr | |
-21.97% | 1.91TCr | |
+8.68% | 1.31TCr | |
+26.99% | 1.22TCr | |
+24.38% | 1.21TCr |
- Stock Market
- Equities
- ADIL Stock
- News Adial Pharmaceuticals, Inc.
- Maxim Group Downgrades Adial Pharmaceuticals to Hold From Buy